Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | NOS1 | P29475 | 1/20 | 0.58 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7162438 | 0.93 | MAOB (0.62) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL12370654 | 0.92 | ALDH1A1 (0.54) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL13883739 | 0.91 | MAOB (0.64) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL7469882 | 0.91 | MAOB (0.56) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL1591503 | 0.91 | TSHR (0.65) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL13828553 | 0.91 | TSHR (0.65) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL1590940 | 0.91 | TSHR (0.65) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL3683494 | 0.91 | TSHR (0.65) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL2623452 | 0.91 | TSHR (0.65) | MAOBALDH1A1MAPTKMT2ANOS1 | |
| SCHEMBL23071123 | 0.90 | ALDH1A1 (0.55) | MAOBALDH1A1MAPTKMT2ANOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040718-B2 | Hybrid host materials for electrophosphorescent devices | THE UNIVERSITY OF ROCHESTER (US) | 2015-05-26 | — | — | US | disclosed |
| WO-2010085676-A1 | HYBRID HOST MATERIALS FOR ELECTROPHOSPHORESCENT DEVICES | UNIVERSITY OF ROCHESTER (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20100184942-A1 | Hybrid Host Materials For Electrophosphorescent Devices | THE UNIVERSITY OF ROCHESTER | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184942-A1 | Hybrid Host Materials For Electrophosphorescent Devices | SLC29A2, SLC43A3, SLC29A1 | MAOB 2567/4885ALDH1A1 2164/4885MAPT 218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.